CRIS - CURIS INC
1.89
-0.210 -11.111%
Share volume: 80,171
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$2.10
-0.21
-0.10%
Summary score
42%
Profitability
25%
Dept financing
49%
Liquidity
48%
Performance
55%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2013 - 31-Dec-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-58.14%
Return on assets
-15.79%
Return on sales
-538.97%
Return on invested capital
506.56%
Total debt ratio
56.39%
Debt ratio change over timeo
0%
Current Ratio
4.93%
Quick Ratio
0%
Cash Position Ratio
2.19%
Short-term ratios 31-Dec-2016 - 31-Dec-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-77.55%
Return on assets
-17.05%
Return on sales
-538.26%
Return on invested capital
440.27%
Total debt ratio
71.74%
Debt ratio change over timeo
0%
Current Ratio
4.82%
Quick Ratio
0%
Cash Position Ratio
2.99%
Last quarter ratios 31-Dec-2017
The data are presented for the financials results of the last quarter.
Return on equity
-33.46%
Return on assets
-9.66%
Return on sales
-218.49%
Return on invested capital
174.6%
Total debt ratio
67.49%
Debt ratio change over time
0%
Current Ratio
4.56%
Quick Ratio
0%
Cash Position Ratio
2.72%
Performance ratios (change over 4 years) 31-Dec-2013 - 31-Dec-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CRIS | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | -58.14% | 3.6% | 11.07% | 0% |
| Return on assets | -15.79% | 3.16% | 6.86% | 0% |
| Return on sales | -538.97% | 43.39% | 56.58% | 0% |
| Return on invested capital | 506.56% | 5.43% | 9.14% | 0% |
| Profitability | 25% | 39% | 75% | 0% |
| Total debt ratio | 56.39% | 61.64% | 66.49% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 46% | 23% | 25% | 0% |
| Current Ratio | 4.82% | 5.54% | 3.09% | 0% |
| Quick Ratio | 0% | 5.21% | 2.96% | 0% |
| Cash Position Ratio | 2.99% | 0.36% | 1.43% | 0% |
| Liquididy | 50% | 54% | 40% | 0% |
| Short-term ratios | CRIS | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | -77.55% | 0.73% | 4.7% | 0% |
| Return on assets | -17.05% | 3.16% | 5.67% | 0% |
| Return on sales | -538.26% | 44.06% | 53.59% | 0% |
| Return on invested capital | 440.27% | 2.07% | 5.57% | 0% |
| Profitability | 25% | 38% | 75% | 0% |
| Total debt ratio | 71.74% | 62.28% | 64.86% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 22% | 23% | 0% |
| Current Ratio | 4.82% | 5.54% | 3.09% | 0% |
| Quick Ratio | 0% | 5.21% | 2.96% | 0% |
| Cash Position Ratio | 2.99% | 0.36% | 1.43% | 0% |
| Liquididy | 47% | 53% | 40% | 0% |
